Hear from a global team on the crucial legal and regulatory topics investors need to know when buying or investing in Clinical Trial Site Management Organizations.
Investing in pharma services is complicated, but our team...more
On 11 June 2021, the German Federal Parliament approved the draft bill on corporate due diligence in supply chains (Supply Chain Due Diligence Act), which was approved by the German Federal Council without any changes on 25...more
7/13/2021
/ Acquisitions ,
Annual Reports ,
Competent Authority (CA) ,
Due Diligence ,
Duty of Care ,
Environmental Social & Governance (ESG) ,
EU ,
France ,
Germany ,
Human Rights ,
Italy ,
Liability ,
Mergers ,
Modern Slavery Act ,
New Legislation ,
Risk Management ,
Sanctions ,
Supply Chain ,
Sustainability ,
UK ,
United States ,
Whistleblowers
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team...more
5/5/2020
/ Acquisitions ,
Contact Tracing ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Divestiture ,
Due Diligence ,
Foreign Investment ,
Health Care Providers ,
Intellectual Property Protection ,
Joint Venture ,
Life Sciences ,
Medical Testing ,
Mergers ,
Partnerships ,
Pharmaceutical Industry ,
Regulatory Oversight ,
Vaccinations ,
Virus Testing ,
Webinars
Data Inspections in China: Increased Supervision and Compliance -
Data protection inspections have become more frequent for companies with operations in China. Many companies are struggling for guidance on how to...more
Nationalism and Cross-Border M&A: Navigating Populist Politics in Deal Making -
More than half of the G20 countries voted-in campaigns that focused on harming foreign, outside interests as a means to strengthen domestic...more
9/5/2017
/ ACOs ,
Acquisitions ,
Arbitration ,
Arbitration Awards ,
Artificial Intelligence ,
China ,
Customer-Loyalty Programs ,
Data Breach ,
Data Controller ,
Data Privacy ,
Due Diligence ,
EU ,
General Data Protection Regulation (GDPR) ,
Health Care Providers ,
Hospitals ,
India ,
Joint Venture ,
Long-Term Investment Funds ,
Mergers ,
Personal Data ,
Shareholders ,
UK